Korea Preclinical Evaluation Center
4D19
introduction
The Korea Preclinical Evaluation Center (KPEC) at KRIBB is a mission-oriented national drug development hub for continuous, proactive, and rapid responses to emerging infectious diseases. KPEC accelerates vaccine and therapeutic development through customized preclinical support.
Major Item introduction
KPEC advances a one-stop preclinical support system for infectious disease response through ABL3 infrastructure and advanced preclinical evaluation methods. KPEC also supports AI-driven digital bio platforms and the Pandemic Emergency Bank (PEB) for advanced bio research.
